{"id":"https://openalex.org/W4415200096","doi":"https://doi.org/10.1200/go-25-00326","title":"Review of All Solid Tumor Drug Approvals From 2019 to 2024 by US Food and Drug Administration, European Medicines Agency, and Brazilian Health Regulatory Agency","display_name":"Review of All Solid Tumor Drug Approvals From 2019 to 2024 by US Food and Drug Administration, European Medicines Agency, and Brazilian Health Regulatory Agency","publication_year":2025,"publication_date":"2025-10-01","ids":{"openalex":"https://openalex.org/W4415200096","doi":"https://doi.org/10.1200/go-25-00326","pmid":"https://pubmed.ncbi.nlm.nih.gov/41092262"},"language":"en","primary_location":{"id":"doi:10.1200/go-25-00326","doi":"https://doi.org/10.1200/go-25-00326","is_oa":true,"landing_page_url":"https://doi.org/10.1200/go-25-00326","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/GO-25-00326","source":{"id":"https://openalex.org/S4210209558","display_name":"JCO Global Oncology","issn_l":"2687-8941","issn":["2687-8941"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JCO Global Oncology","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://ascopubs.org/doi/pdfdirect/10.1200/GO-25-00326","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5033554585","display_name":"Rafael Balsini Barreto","orcid":"https://orcid.org/0009-0008-2134-0422","observed_orcids":["https://orcid.org/0009-0008-2134-0422"]},"institutions":[{"id":"https://openalex.org/I4210163308","display_name":"Centro de Pesquisas Oncol\u00f3gicas","ror":"https://ror.org/052dytr59","country_code":"BR","type":"facility","lineage":["https://openalex.org/I4210163308"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Rafael Balsini Barreto","raw_affiliation_strings":["Centro de Pesquisas Oncol\u00f3gicas\u2014CEPON, Department of Clinical Oncology, Florian\u00f3polis/SC, Brazil"],"raw_orcid":"https://orcid.org/0009-0008-2134-0422","affiliations":[{"raw_affiliation_string":"Centro de Pesquisas Oncol\u00f3gicas\u2014CEPON, Department of Clinical Oncology, Florian\u00f3polis/SC, Brazil","institution_ids":["https://openalex.org/I4210163308"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110498210","display_name":"M\u00e1rio Henrique Furlanetto Miranda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163308","display_name":"Centro de Pesquisas Oncol\u00f3gicas","ror":"https://ror.org/052dytr59","country_code":"BR","type":"facility","lineage":["https://openalex.org/I4210163308"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"M\u00e1rio Henrique Furlanetto Miranda","raw_affiliation_strings":["Centro de Pesquisas Oncol\u00f3gicas\u2014CEPON, Department of Clinical Oncology, Florian\u00f3polis/SC, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro de Pesquisas Oncol\u00f3gicas\u2014CEPON, Department of Clinical Oncology, Florian\u00f3polis/SC, Brazil","institution_ids":["https://openalex.org/I4210163308"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077320304","display_name":"Camila Marchi Blatt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163308","display_name":"Centro de Pesquisas Oncol\u00f3gicas","ror":"https://ror.org/052dytr59","country_code":"BR","type":"facility","lineage":["https://openalex.org/I4210163308"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Camila Marchi Blatt","raw_affiliation_strings":["Centro de Pesquisas Oncol\u00f3gicas\u2014CEPON, Department of Clinical Oncology, Florian\u00f3polis/SC, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro de Pesquisas Oncol\u00f3gicas\u2014CEPON, Department of Clinical Oncology, Florian\u00f3polis/SC, Brazil","institution_ids":["https://openalex.org/I4210163308"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069990566","display_name":"B\u00e1rbara Andressa Uliana","orcid":"https://orcid.org/0009-0009-0716-1062","observed_orcids":["https://orcid.org/0009-0009-0716-1062"]},"institutions":[{"id":"https://openalex.org/I4210163308","display_name":"Centro de Pesquisas Oncol\u00f3gicas","ror":"https://ror.org/052dytr59","country_code":"BR","type":"facility","lineage":["https://openalex.org/I4210163308"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"B\u00e1rbara Andressa Uliana","raw_affiliation_strings":["Centro de Pesquisas Oncol\u00f3gicas\u2014CEPON, Department of Clinical Oncology, Florian\u00f3polis/SC, Brazil"],"raw_orcid":"https://orcid.org/0009-0009-0716-1062","affiliations":[{"raw_affiliation_string":"Centro de Pesquisas Oncol\u00f3gicas\u2014CEPON, Department of Clinical Oncology, Florian\u00f3polis/SC, Brazil","institution_ids":["https://openalex.org/I4210163308"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5032643945","display_name":"Denize Bodnar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163308","display_name":"Centro de Pesquisas Oncol\u00f3gicas","ror":"https://ror.org/052dytr59","country_code":"BR","type":"facility","lineage":["https://openalex.org/I4210163308"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Denize Bodnar","raw_affiliation_strings":["Centro de Pesquisas Oncol\u00f3gicas\u2014CEPON, Department of Clinical Oncology, Florian\u00f3polis/SC, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro de Pesquisas Oncol\u00f3gicas\u2014CEPON, Department of Clinical Oncology, Florian\u00f3polis/SC, Brazil","institution_ids":["https://openalex.org/I4210163308"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210163308"],"apc_list":{"value":2472,"currency":"USD","value_usd":2472},"apc_paid":{"value":2472,"currency":"USD","value_usd":2472},"fwci":0.7299,"has_fulltext":true,"cited_by_count":4,"citation_normalized_percentile":{"value":0.64394619,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"11","issue":"11","first_page":"e2500326","last_page":"e2500326"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.5029000043869019,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.5029000043869019,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11649","display_name":"Pharmaceutical industry and healthcare","score":0.16850000619888306,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13417","display_name":"Biomedical Ethics and Regulation","score":0.059700001031160355,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/oncology-drug-regulation","display_name":"oncology drug regulation","score":0.7829999923706055},{"id":"https://openalex.org/keywords/fda","display_name":"FDA","score":0.6050000190734863},{"id":"https://openalex.org/keywords/ema","display_name":"EMA","score":0.9869999885559082},{"id":"https://openalex.org/keywords/anvisa","display_name":"ANVISA","score":0.9990000128746033},{"id":"https://openalex.org/keywords/indication-expansion","display_name":"indication expansion","score":0.46799999475479126},{"id":"https://openalex.org/keywords/access-to-medicines","display_name":"access to medicines","score":0.3630000054836273}],"concepts":[{"id":"https://openalex.org/C2992293740","wikidata":"https://www.wikidata.org/wiki/Q4781752","display_name":"Drug approval","level":3,"score":0.6812999844551086},{"id":"https://openalex.org/C2778917124","wikidata":"https://www.wikidata.org/wiki/Q7309705","display_name":"Regulatory science","level":2,"score":0.6682000160217285},{"id":"https://openalex.org/C108170787","wikidata":"https://www.wikidata.org/wiki/Q3951828","display_name":"Agency (philosophy)","level":2,"score":0.6503000259399414},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.6459000110626221},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5813999772071838},{"id":"https://openalex.org/C3019398576","wikidata":"https://www.wikidata.org/wiki/Q1639780","display_name":"Regulatory agency","level":2,"score":0.555400013923645},{"id":"https://openalex.org/C3018890749","wikidata":"https://www.wikidata.org/wiki/Q204711","display_name":"Food and drug administration","level":2,"score":0.5037000179290771},{"id":"https://openalex.org/C3020340455","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Cancer drugs","level":3,"score":0.4706000089645386},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.42399999499320984},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.3919999897480011},{"id":"https://openalex.org/C2777589142","wikidata":"https://www.wikidata.org/wiki/Q6770899","display_name":"Marketing authorization","level":2,"score":0.37860000133514404},{"id":"https://openalex.org/C2775832928","wikidata":"https://www.wikidata.org/wiki/Q407954","display_name":"Expanded access","level":2,"score":0.3537999987602234},{"id":"https://openalex.org/C2780511413","wikidata":"https://www.wikidata.org/wiki/Q18749628","display_name":"Regulatory affairs","level":2,"score":0.33239999413490295},{"id":"https://openalex.org/C2993777677","wikidata":"https://www.wikidata.org/wiki/Q507443","display_name":"Drug industry","level":2,"score":0.3303999900817871},{"id":"https://openalex.org/C2910001868","wikidata":"https://www.wikidata.org/wiki/Q458","display_name":"European union","level":2,"score":0.32120001316070557},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2994000017642975},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2985999882221222},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.29739999771118164},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.29739999771118164},{"id":"https://openalex.org/C3019492093","wikidata":"https://www.wikidata.org/wiki/Q29468924","display_name":"Access to medicines","level":3,"score":0.2962000072002411},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.29170000553131104},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.28610000014305115},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.27649998664855957},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.27639999985694885},{"id":"https://openalex.org/C2908795282","wikidata":"https://www.wikidata.org/wiki/Q7240896","display_name":"Drug pricing","level":2,"score":0.2720000147819519},{"id":"https://openalex.org/C2777351106","wikidata":"https://www.wikidata.org/wiki/Q49371","display_name":"Legislation","level":2,"score":0.2700999975204468},{"id":"https://openalex.org/C138816342","wikidata":"https://www.wikidata.org/wiki/Q189603","display_name":"Public health","level":2,"score":0.26820001006126404},{"id":"https://openalex.org/C75480439","wikidata":"https://www.wikidata.org/wiki/Q1367466","display_name":"Orphan drug","level":2,"score":0.2619999945163727},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.25519999861717224}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001938","descriptor_name":"Brazil","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005060","descriptor_name":"Europe","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006077","descriptor_name":"Government Agencies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014486","descriptor_name":"United States Food and Drug Administration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017277","descriptor_name":"Drug Approval","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1200/go-25-00326","doi":"https://doi.org/10.1200/go-25-00326","is_oa":true,"landing_page_url":"https://doi.org/10.1200/go-25-00326","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/GO-25-00326","source":{"id":"https://openalex.org/S4210209558","display_name":"JCO Global Oncology","issn_l":"2687-8941","issn":["2687-8941"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JCO Global Oncology","raw_type":"journal-article"},{"id":"pmid:41092262","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41092262","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JCO global oncology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:d2feeccede2845bd90dac8341ce3668b","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/d2feeccede2845bd90dac8341ce3668b","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"JCO Global Oncology, Iss 11 (2025)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1200/go-25-00326","doi":"https://doi.org/10.1200/go-25-00326","is_oa":true,"landing_page_url":"https://doi.org/10.1200/go-25-00326","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/GO-25-00326","source":{"id":"https://openalex.org/S4210209558","display_name":"JCO Global Oncology","issn_l":"2687-8941","issn":["2687-8941"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JCO Global Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[{"display_name":"Systematic Review","id":"https://openalex.org/study-designs/systematic-review"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4415200096.pdf","grobid_xml":"https://content.openalex.org/works/W4415200096.grobid-xml"},"referenced_works_count":23,"referenced_works":["https://openalex.org/W2110547498","https://openalex.org/W2761792472","https://openalex.org/W2793539832","https://openalex.org/W2926052258","https://openalex.org/W2947583588","https://openalex.org/W2961900003","https://openalex.org/W2974839292","https://openalex.org/W2986067687","https://openalex.org/W3020771563","https://openalex.org/W3045364476","https://openalex.org/W3092243224","https://openalex.org/W3168910981","https://openalex.org/W3173705400","https://openalex.org/W3175173749","https://openalex.org/W4200431190","https://openalex.org/W4308179948","https://openalex.org/W4308183725","https://openalex.org/W4376881132","https://openalex.org/W4392180309","https://openalex.org/W4394063884","https://openalex.org/W4401353026","https://openalex.org/W4402544434","https://openalex.org/W4408884282"],"related_works":["https://openalex.org/W4399305629","https://openalex.org/W4401353026","https://openalex.org/W7161262304","https://openalex.org/W1989308735","https://openalex.org/W4415929989","https://openalex.org/W4407095959","https://openalex.org/W3004332746","https://openalex.org/W2297401298","https://openalex.org/W4399150303","https://openalex.org/W2308998463"],"abstract_inverted_index":{"PURPOSE:":[0],"Regulatory":[1,37],"agencies":[2],"play":[3],"a":[4,41,179],"pivotal":[5,98,207],"role":[6],"in":[7,158,191,237],"evaluating":[8],"clinical":[9,55,115],"evidence":[10,49,116],"for":[11,68,127,255],"oncology":[12,256],"drug":[13,257],"approvals.":[14,202],"This":[15],"study":[16,104],"aimed":[17],"to":[18,79,173,176],"compare":[19],"approved":[20,71,111,131,139,149],"indications":[21,67,126],"across":[22],"the":[23,44,47,73,97,107,110,114,121,133,152],"US":[24],"Food":[25],"and":[26,34,50,54,66,92,106,113,142,151,165,185,196,219,233,241,259],"Drug":[27],"Administration":[28],"(FDA),":[29],"European":[30],"Medicines":[31],"Agency":[32,38],"(EMA),":[33],"Brazilian":[35],"Health":[36],"(ANVISA),":[39],"with":[40,87],"focus":[42],"on":[43],"robustness":[45],"of":[46,160,163,167,193,198,205,250],"supporting":[48],"consistency":[51],"between":[52,109,148],"labeling":[53],"trial":[56],"data.":[57],"METHODS:":[58],"A":[59,203],"systematic":[60],"review":[61],"identified":[62],"all":[63],"new":[64,125],"drugs":[65],"solid":[69,128],"tumors":[70,129],"by":[72,90,132,140,145,183],"FDA":[74],"from":[75],"January":[76],"1,":[77],"2019,":[78],"December":[80],"31,":[81],"2024.":[82],"Each":[83],"approval":[84],"was":[85],"cross-referenced":[86],"corresponding":[88],"decisions":[89],"EMA":[91,141,184],"ANVISA.":[93,146,186],"For":[94],"each":[95],"indication,":[96],"trial's":[99],"design,":[100],"primary":[101,153],"end":[102,154,227],"point,":[103],"population,":[105],"concordance":[108],"label":[112,174],"were":[117,130,137,189,229],"identified.":[118],"RESULTS:":[119],"During":[120],"6-year":[122],"period,":[123],"199":[124],"FDA;":[134],"138":[135],"(69.3%)":[136],"also":[138],"124":[143,199],"(62.3%)":[144],"Discrepancies":[147],"labels":[150],"point":[155],"population":[156],"occurred":[157],"10.0%":[159],"FDA,":[161],"18.8%":[162],"EMA,":[164],"12.9%":[166],"ANVISA":[168],"approvals,":[169,211,243],"most":[170,225],"often":[171],"due":[172],"restrictions":[175],"subgroups,":[177],"indicating":[178],"more":[180],"conservative":[181],"approach":[182],"Labeling":[187],"differences":[188],"noted":[190],"19":[192],"139":[194],"FDA-EMA":[195],"10":[197],"FDA-ANVISA":[200],"shared":[201],"total":[204],"190":[206],"trials":[208,240],"supported":[209],"these":[210],"including":[212,236],"three":[213],"phase":[214,217,221,238],"I,":[215],"59":[216],"II,":[218],"128":[220],"III":[222,239],"studies.":[223],"The":[224],"frequent":[226],"points":[228],"overall":[230,246],"response":[231],"rate":[232],"progression-free":[234],"survival,":[235],"regular":[242],"rather":[244],"than":[245],"survival":[247],"or":[248],"quality":[249],"life.":[251],"CONCLUSION:":[252],"cy":[253],"implications":[254],"access":[258],"adoption":[260],"worldwide.":[261]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":1}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2025-10-15T00:00:00"}